GSK will use promising results from two studies of its experimental chronic hepatitis B therapy to support planned regulatory ...

Childhood vaccinations are tried and true way to keep America's children healthy. So why are they being rolled back?

GSK will be filing for approval of bepirovirsen in hepatitis B to global regulatory authorities based on the Phase III data.

Hepatitis B is a virus that can damage the liver and lead to lifelong health problems. The hepatitis B vaccine prevents short ...

GSK's experimental drug to treat chronic hepatitis B infection met the main goal in two closely watched studies, the ...

The U.S. is cutting the Hepatitis B vaccine from its recommended list. But here's a place where the medical establishment — ...

GSK’s potential “functional cure” for hepatitis B drug has proven its worth in a pair of hotly anticipated phase 3 studies, setting up the pharma for a push to the FDA.

The change follows a controversial recommendation from the CDC's Advisory Committee on Immunization Practices (ACIP) to no ...

The Tuskegee syphilis study stands as one of the greatest moral failures in American medical history, a reminder of what ...

Since roughly 1991, the U.S. Centers for Disease Control and Prevention has recommended all babies get a dose of the ...

If something as fundamental as newborn vaccination schedule can be revised, it raises an important question: Is the science ...

Topline data were announced from two phase 3 studies evaluating bepirovirsen for the treatment of chronic hepatitis B.